| 0.4 |
3.9 |
GO:0021840 |
directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
| 0.4 |
1.1 |
GO:0046013 |
regulation of T cell homeostatic proliferation(GO:0046013) |
| 0.3 |
0.9 |
GO:0051795 |
positive regulation of catagen(GO:0051795) activation of meiosis(GO:0090427) |
| 0.2 |
0.9 |
GO:0002426 |
immunoglobulin production in mucosal tissue(GO:0002426) |
| 0.2 |
0.9 |
GO:2000007 |
apoptotic process involved in endocardial cushion morphogenesis(GO:0003277) intermediate mesoderm morphogenesis(GO:0048390) intermediate mesoderm formation(GO:0048391) intermediate mesodermal cell differentiation(GO:0048392) regulation of cardiac muscle fiber development(GO:0055018) positive regulation of cardiac muscle fiber development(GO:0055020) bud dilation involved in lung branching(GO:0060503) BMP signaling pathway involved in ureter morphogenesis(GO:0061149) renal system segmentation(GO:0061150) BMP signaling pathway involved in renal system segmentation(GO:0061151) pulmonary artery endothelial tube morphogenesis(GO:0061155) regulation of transcription from RNA polymerase II promoter involved in mesonephros development(GO:0061216) BMP signaling pathway involved in nephric duct formation(GO:0071893) negative regulation of branch elongation involved in ureteric bud branching(GO:0072096) negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway(GO:0072097) anterior/posterior pattern specification involved in ureteric bud development(GO:0072099) specification of ureteric bud anterior/posterior symmetry(GO:0072100) specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway(GO:0072101) ureter epithelial cell differentiation(GO:0072192) negative regulation of mesenchymal cell proliferation involved in ureter development(GO:0072200) positive regulation of cell proliferation involved in outflow tract morphogenesis(GO:1901964) cardiac jelly development(GO:1905072) regulation of metanephric S-shaped body morphogenesis(GO:2000004) negative regulation of metanephric S-shaped body morphogenesis(GO:2000005) regulation of metanephric comma-shaped body morphogenesis(GO:2000006) negative regulation of metanephric comma-shaped body morphogenesis(GO:2000007) |
| 0.2 |
1.7 |
GO:2000189 |
positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.2 |
0.9 |
GO:0042271 |
susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.1 |
1.0 |
GO:0061113 |
pancreas morphogenesis(GO:0061113) |
| 0.1 |
1.6 |
GO:0090324 |
negative regulation of oxidative phosphorylation(GO:0090324) |
| 0.1 |
0.4 |
GO:0014016 |
neuroblast differentiation(GO:0014016) |
| 0.1 |
1.6 |
GO:0061087 |
positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.1 |
0.3 |
GO:0016260 |
selenocysteine biosynthetic process(GO:0016260) |
| 0.1 |
1.9 |
GO:0001833 |
inner cell mass cell proliferation(GO:0001833) |
| 0.1 |
0.6 |
GO:0034959 |
substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.1 |
0.7 |
GO:1903435 |
positive regulation of constitutive secretory pathway(GO:1903435) |
| 0.1 |
0.8 |
GO:0006627 |
protein processing involved in protein targeting to mitochondrion(GO:0006627) |
| 0.1 |
0.3 |
GO:0002416 |
IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
| 0.1 |
0.3 |
GO:0045726 |
positive regulation of integrin biosynthetic process(GO:0045726) |
| 0.1 |
0.5 |
GO:0048539 |
immunoglobulin biosynthetic process(GO:0002378) hematopoietic stem cell migration(GO:0035701) bone marrow development(GO:0048539) |
| 0.1 |
1.3 |
GO:0046085 |
adenosine metabolic process(GO:0046085) |
| 0.1 |
0.2 |
GO:0035711 |
plasmacytoid dendritic cell activation(GO:0002270) regulation of restriction endodeoxyribonuclease activity(GO:0032072) T-helper 1 cell activation(GO:0035711) |
| 0.1 |
0.3 |
GO:0000117 |
regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.1 |
0.5 |
GO:1902748 |
melanocyte migration(GO:0097324) positive regulation of lens fiber cell differentiation(GO:1902748) |
| 0.1 |
1.6 |
GO:0090331 |
negative regulation of platelet aggregation(GO:0090331) |
| 0.1 |
0.5 |
GO:0000707 |
meiotic DNA recombinase assembly(GO:0000707) |
| 0.0 |
0.4 |
GO:0033353 |
S-adenosylmethionine cycle(GO:0033353) |
| 0.0 |
0.2 |
GO:0060023 |
soft palate development(GO:0060023) |
| 0.0 |
0.2 |
GO:1903028 |
positive regulation of opsonization(GO:1903028) |
| 0.0 |
0.6 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.0 |
0.2 |
GO:1902725 |
negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) negative regulation of satellite cell differentiation(GO:1902725) |
| 0.0 |
0.6 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.0 |
0.3 |
GO:0014807 |
regulation of somitogenesis(GO:0014807) |
| 0.0 |
0.1 |
GO:0002881 |
negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
| 0.0 |
0.3 |
GO:0001757 |
somite specification(GO:0001757) |
| 0.0 |
1.1 |
GO:0021516 |
dorsal spinal cord development(GO:0021516) |
| 0.0 |
0.3 |
GO:1904694 |
negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.0 |
0.2 |
GO:0051970 |
negative regulation of transmission of nerve impulse(GO:0051970) |
| 0.0 |
0.6 |
GO:1901078 |
negative regulation of relaxation of muscle(GO:1901078) negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 0.0 |
0.2 |
GO:0036367 |
adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
| 0.0 |
0.3 |
GO:0000730 |
DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 0.0 |
0.3 |
GO:0010989 |
negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 0.0 |
0.1 |
GO:2000342 |
negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
| 0.0 |
0.8 |
GO:0007016 |
cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.0 |
0.4 |
GO:0070257 |
positive regulation of mucus secretion(GO:0070257) |
| 0.0 |
0.2 |
GO:0001920 |
negative regulation of receptor recycling(GO:0001920) |
| 0.0 |
0.9 |
GO:0089711 |
L-glutamate transmembrane transport(GO:0089711) |
| 0.0 |
0.5 |
GO:0014029 |
neural crest formation(GO:0014029) |
| 0.0 |
0.9 |
GO:0006625 |
protein targeting to peroxisome(GO:0006625) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
| 0.0 |
0.3 |
GO:2000324 |
positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.0 |
0.1 |
GO:1903527 |
positive regulation of membrane tubulation(GO:1903527) |
| 0.0 |
0.3 |
GO:0051388 |
positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.0 |
0.1 |
GO:0061743 |
motor learning(GO:0061743) |
| 0.0 |
0.1 |
GO:0019082 |
viral protein processing(GO:0019082) regulation of nerve growth factor production(GO:0032903) negative regulation of nerve growth factor production(GO:0032904) dibasic protein processing(GO:0090472) |
| 0.0 |
0.1 |
GO:0098582 |
innate vocalization behavior(GO:0098582) |
| 0.0 |
0.1 |
GO:0006422 |
aspartyl-tRNA aminoacylation(GO:0006422) |
| 0.0 |
0.1 |
GO:0015722 |
canalicular bile acid transport(GO:0015722) pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
| 0.0 |
0.1 |
GO:0051799 |
negative regulation of hair follicle development(GO:0051799) |
| 0.0 |
0.7 |
GO:0000038 |
very long-chain fatty acid metabolic process(GO:0000038) |
| 0.0 |
0.3 |
GO:1902083 |
negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.0 |
0.1 |
GO:0048619 |
embryonic hindgut morphogenesis(GO:0048619) |
| 0.0 |
0.1 |
GO:0001550 |
ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
| 0.0 |
0.1 |
GO:0070127 |
tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.0 |
0.4 |
GO:0007638 |
mechanosensory behavior(GO:0007638) |
| 0.0 |
0.3 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.0 |
1.4 |
GO:0042795 |
snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 0.0 |
0.2 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.0 |
0.1 |
GO:0046604 |
positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.0 |
0.1 |
GO:0042421 |
norepinephrine biosynthetic process(GO:0042421) |
| 0.0 |
0.1 |
GO:0051594 |
detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
| 0.0 |
1.4 |
GO:0042246 |
tissue regeneration(GO:0042246) |
| 0.0 |
0.1 |
GO:1904721 |
negative regulation of mRNA cleavage(GO:0031438) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
| 0.0 |
0.2 |
GO:0050966 |
detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
| 0.0 |
0.1 |
GO:0051612 |
negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.0 |
0.1 |
GO:0030242 |
pexophagy(GO:0030242) |
| 0.0 |
0.2 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
| 0.0 |
0.4 |
GO:0003416 |
endochondral bone growth(GO:0003416) |
| 0.0 |
0.2 |
GO:1904354 |
negative regulation of telomere capping(GO:1904354) |
